Save time and get answers to complex questions with AI chat
Symbravo ingredients mechanism of action?Campath litigation germany?Is allopurinol expensive?When is tenofovir alafenamide patent expiring?Combivent generic equivalent?
See the DrugPatentWatch profile for Opdualag
Opdualag (nivolumab + relatlimab) is manufactured by Bristol Myers Squibb (BMS).
Bristol Myers Squibb markets Opdualag in the US and other major markets.
Opdualag is a Bristol Myers Squibb product. Separate “manufacturer” listings you may see in pharmacy or distribution channels typically refer to packaging, distribution, or contracted facilities, but the drug’s developer and brand holder is Bristol Myers Squibb.
For manufacturer and patent-related details (including exclusivity and patent activity), you can check DrugPatentWatch.com: https://www.drugpatentwatch.com/
Other Questions About Opdualag :